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Abstract
Background: Hypergonadotropic hypogonadism (HH) is a genetically heteroge-
neous disorder that usually presents with amenorrhea, atrophic ovaries, and low
estrogen. Most cases of HH are idiopathic and nonsyndromic. Nucleoporin 107
(NUP107), a protein involved in transport between cytoplasm and nucleus with
putative roles in meiosis/mitosis progression, was recently implicated as a cause
of HH. We identified a NUP107 genetic variant in a nonconsanguineous family
with two sisters affected with primary amenorrhea and HH, and generated a
mouse model that carried the human variant.
Methods: We performed a high-resolution X-chromosome microarray and whole
exome sequencing on parents and two sisters with HH to identify pathogenic variants.
We generated a mouse model of candidate NUP107 variant using CRISPR/Cas9.
Results: Whole exome sequencing identified a novel and rare missense variant in
the NUP107 gene (c.1063C>T, p.R355C) in both sisters with HH. In order to deter-
mine functional significance of this variant, we used CRISPR/Cas9 to introduce the
human variant into the mouse genome. Mice with the homolog of the R355C variant,
as well as the nine base pairs deletion in Nup107 had female subfertility.
Conclusions: Our findings indicate that NUP107 R355C variant falls in the cate-
gory of variant of unknown significance as the cause of HH and infertility.
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1 | INTRODUCTION
Hypergonadotropic hypogonadism (HH), also known as
premature ovarian insufficiency, affects 1–4% of women
and is defined as a cessation of menses prior to age 40,
with elevated follicle-stimulating hormone (FSH) and low
serum estradiol levels. Women with HH can present with
amenorrhea (primary or secondary), hypogonadism, and
hypoestrogenic symptoms (i.e., hot flashes, vaginal dryness,
premature osteoporosis). HH is genetically heterogeneous,
with few genes identified, and can be idiopathic and non-
syndromic or part of a genetic syndrome. Pathogenesis of
HH includes abnormalities of the X chromosome or auto-
somes and can also be due to autoimmune, infectious, and*These authors contributed equally to this work.
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environmental causes (LM, 2009). For a subset of idio-
pathic cases, a genetic basis has been shown, and FMR1
(MIM 309550), FSHR (MIM 136435), PMM2 (MIM
601785), GALT (MIM 606999), AIRE (MIM 607358), and
FOXL2 (MIM 605597) are the genes currently recom-
mended for clinical genetic testing (Practice Committee of
American Society for Reproductive Medicine, 2008).
Recently, a nucleotide missense variant in NUP107
(c.1339G>A, p.D447N, MIM 607617) was associated with
HH and XX female gonadal dysgenesis in a consan-
guineous Palestinian family (Weinberg-Shukron et al.,
2015). Nucleoporins assemble to form nuclear pore com-
plexes (NPCs), which are embedded throughout the dou-
ble-membrane nuclear envelope. NPCs are regarded as the
gatekeepers of the nucleus and tightly control all nucleocy-
toplasmic transport (Kabachinski & Schwartz, 2015).
Nucleoporin 107 kDa (NUP107) is evolutionarily con-
served, and it is a key scaffold protein in NPC assembly,
as a part of the Nup107–Nup160 subcomplex (Walther
et al., 2003; Belgareh et al., 2001).
Here we report a new NUP107 (c.1063C>T, p.R355C)
variant, discovered in two sisters who were diagnosed with
primary amenorrhea and HH. The R355 amino acid is con-
served across species, and this variant is present at low fre-
quency in heterozygous state (1.81 9 105) in the
gnomAD database (Lek et al., 2016). The R355 amino acid
is predicted to form a salt bridge with D447, which is
important to stabilize overall NUP107 protein structure
(Weinberg-Shukron et al., 2015). Classification of nucleo-
tide variants for clinical use requires either epidemiologic
or in vitro and in vivo assays that corroborate or disprove
pathogenicity of the variant. We generated a mouse model
to determine functional significance of the NUP107
(c.1063C>T, p.R355C) variant.
2 | METHODS
2.1 | Study approval
The recruitment of fertile women from Magee-Womens
Hospital was approved by the IRB of the University of
Pittsburgh. Written informed consent was obtained from all
participating subjects. All experimental and surgical proce-
dures complied with the Guide for the Care and Use of
Laboratory Animals were approved by the Institutional
Animal Care and Use Committee at the University of Pitts-
burgh.
2.2 | Whole exome sequencing
We used HaloPlex exome capture kit (Agilent) to capture
exons and splice sites, and whole exome sequencing
(WES) was performed on an Illumina HiSeq 2500.
Sequence reads were mapped to the human reference gen-
ome (GRCh37/h19) using Burrows–Wheeler Aligner ver-
sion 0.7.3a MEM (maximal exact match). Local
realignment around insertions and deletions and recalibra-
tion of read base quality were conducted with Genome
Analysis Toolkit (GATK) version 2.8. GATK Haplotype
Caller was used for calling variants.
2.3 | Copy number variation
Microarray hybridization experiments and analyses were
performed according to the manufacturer’s protocol using
pooled female DNA (G152, Promega) as the reference and
as described previously (Yatsenko et al., 2015). Copy num-
ber variants were detected using the aberration detection
method 2 (ADM-2) algorithm and displayed by Cytoge-
nomics v2.5.8 software (Agilent) and compared to a data-
base of apparently copy number variants obtained from
normal control individuals (DGV, http://dgv.tcag.ca) and
other public databases of copy number variants (ClinGen
CNVs, www.clinicalgenome.org; DECIPHER, https://deci
pher.sanger.ac.uk).
2.4 | Generation of transgenic mouse model
We used CRISPR/Cas9n to introduce a corresponding
human missense variant into the mouse Nup107
(c.1066C>T, p.R356C; Figure 2). A pair of single guide
RNAs (sgRNAs)—sgRNA1 and sgRNA2—targeting exon
12 of the Nup107 gene were designed by an Optimized
CRISPR Design tool (http://crispr.mit.edu/) (Figure 2a).
The desired variant site falls inside of the sgRNA-targeted
region. sgRNAs were cloned into PX461 vector, which
contains the D10A Cas9 mutant (Cas9n) sequence and
GFP tag. One 191-nt single-stranded oligodeoxynucleotide
(ssODN) carrying the single nucleotide change was synthe-
sized to be the template of homology-directed repair (Fig-
ure 2b). It contains flanking sequences of 60 nucleotides
on each side that are homologous to the regions of intron
11/exon 12 and exon 12/intron 12, respectively (Figure 2b).
The function of the sgRNA pair and ssODN was validated
by delivering a mix of Cas9n:sgRNA1 + Cas9n:
sgRNA2 + ssODN into neuro-2a cells (data not shown).
The Cas9:sgRNA vectors and ssODN were injected into
the zygote to generate the transgenic mice. After overnight
culture, surviving two-cell embryos were transferred to ICR
pseudopregnant recipients. The successful introduction of
the missense variant c.1066C>T was verified by Sanger
sequencing (Figure 2c). Other regions of the exon 12 were
not changed compared to the wild-type sequences, except a
synonymous variant at c.1068T>C, which was intentionally
modified for creating a HhaI recognition site, GCGC, for
the purpose of mouse genotyping (Figure 2c,d).
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2.5 | Statistics
Data were analyzed using Excel and are presented as
M  SEM. Results were analyzed using two-tailed Stu-
dent’s t test.
3 | RESULTS AND DISCUSSION
A healthy couple of Mexican descent had two daughters
diagnosed with primary ovarian insufficiency (see pedigree
in Figure 1a). There is no known history of consanguinity
in the family. Both sisters presented with primary amenor-
rhea and delayed puberty at 17 and 15 years of age. They
have an older brother who is healthy with normal pubertal
development. Both sisters had a normal 46, XX karyotype,
screened negative for Fragile-X carrier status, had normal
thyroid function and glucose tolerance, and had negative
thyroid and adrenal antibody screens (Table S1). As
expected for HH, their FSH and LH levels were high, with
low levels of estradiol and pelvic ultrasound revealed
atrophic ovaries (Table S1). There was no significant expo-
sure (radiation, chemotherapy) or surgical history to sug-
gest iatrogenic cause for the hypogonadism. Their mother
attained menarche at age 12, and reports having normal
pubertal development and regular menstrual cycles. She
had three uneventful full-term pregnancies. Her medical
history was significant for hypothyroidism, diagnosed at
age 28. There was no known family history of delayed
puberty, infertility, or premature menopause.
We initially utilized a custom-designed oligonucleotide
CGH microarray (Yatsenko et al., 2015) to examine for
pathologic genomic imbalances involving both X-linked
and autosomal genes associated with HH. This oligonu-
cleotide-based 180K CGH microarray has been designed to
achieve high-resolution detection of losses and gains for
397 gonadal genes which include known and candidate
genes implicated in gonadal dysgenesis, HH, steroidogene-
sis, and ovarian and testicular differentiation derived from
studies in humans and animal models (Dangle et al., 2017).
In addition to covering the autosomal regions of the gen-
ome, this microarray platform densely covers X chromo-
some to achieve a resolution of ~0.3–3 kb. No pathologic
copy number variants were identified in the two affected
sisters.
WES was performed on the parents and affected daugh-
ters to identify nucleotide variants that may account for the
idiopathic and nonsyndromic HH. Variants were filtered
for quality and significance as previously reported (AlAsiri
et al., 2015). We filtered for nonsynonymous variants (in
exons or splice sites) that are presumed to be damaging,
with a minor allele frequency of <5% and assumed reces-
sive inheritance given the pedigree. Variants in four genes
(ABCD2, ITPR2, NUP107, THAP2) satisfied the above cri-
teria (Table S2). We further annotated these variants based
on the pathogenicity (Richards et al., 2015) gene expres-
sion profile, protein function, its conservation status, and
any available data from animal experiments. ABCD2 was
expressed in a number of tissues, including ovary, while
NUP107 RNA is highly expressed in the ovaries and
oocytes as per BioGPS RNA profiling in mouse tissues
(Wu et al., 2009). In the human embryonic ovaries,
NUP107 was highly expressed while ABCD2 was not
detectable (data not shown). ABCD2 was ruled out as a
candidate because mouse knockouts had cerebellar and sen-
sory ataxia without infertility (Ferrer et al., 2005). We
focused our attention on the NUP107 (c.1063C>T,
p.R355C) variant as a candidate pathogenic variant, present
in homozygous state in the affected daughters. The
FIGURE 1 NUP107 variant (c.1063C>T, R355C) is present in
two daughters from a nonconsanguineous family. (a) Family members
are designated by Arabic numerals. Horizontal lines between
individuals represent marriage. Vertical lines represent lineage. I-1
and I-2, II-1 and II-2 underwent whole exome sequencing. (b)
Representative chromatograms resulting from Sanger sequencing
following PCR surrounding the NUP107 variant (chr12:69,109,500
GRCh37/hg19). Parents who are heterozygous for the NUP107
c.1063C>T variant show overlapping C and T peaks (WT/MT).
Daughters homozygous for the variant have a single T peak (MT/
MT). (c) The NUP107 residue R355 is highly conserved among
species ranging from fruit flies to humans. The single-nucleotide
variant of C (red) to T is predicted to change the NUP107 355 amino
acid residue from arginine (R) to cysteine (C)
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NUP107 c.1063C>T variant was verified in the family by
Sanger sequencing (Figure 1b). The c.1063C>T variant
was predicted to cause amino acid change p.R355C, at a
highly conserved residue in exon 12 of NUP107 (Fig-
ure 1c), and corresponds to a mouse R356 residue.
We introduced the human missense NUP107 variant
into the mouse using CRISPR/Cas9n to generate a mouse
that carries Nup107 (c.1066C>T, p.R356C) variant
(Figure 2). A total of 18 founder animals were obtained.
One founder carried homozygous missense variant
c.1066C>T verified by Sanger sequencing (Figure 2c).
Other regions of the exon 12 were not changed compared
to the wild-type sequences, except a synonymous variant at
c.1068T>C, which was intentionally modified for creating
a HhaI recognition site, GCGC, for the purpose of mouse
genotyping (Figure 2c,d). Female founders were mated
with wild-type males and F2 generation used for fertility
studies in order to eliminate mosaicism. We mated F2
heterozygotes and confirmed homozygous Nup107R356C
genotypes by Sanger sequencing. Homozygous
Nup107R356C founder females were subfertile when mated
to wild-type males over a period of 12 months (Figure 3b).
The mean number of pups per litter was 8.2  3.1 for
wild-type control, and 5.5  2.3 for Nup107R356C homozy-
gotes mated with wild-type males, a 33% reduction
(p < .001). Nup107 p.R356C heterozygous females fertility
did not significantly differ from wild-type mice. There was
no significant difference between wild-type and
Nup107R356C females in the number of litters per month.
Males homozygous for the Nup107R356C variant were fer-
tile. Homozygous females had grossly normal ovaries and
histology showed a normal range of follicles when com-
pared with the wild-type mice (Figure 3a). Males homozy-
gous for the Nup107R356C were also fertile and testes
FIGURE 2 CRISPR/Cas9 mediated modeling of the human NUP107 c.1063C>T variant in mice by introducing a missense variant
(c.1066C>T) into mouse Nup107 gene. (a) Sequences of a pair of sgRNAs (underlined in blue lines) that target Nup107 exon 12. The PAM
sequences are underlined in red. (b) The sequence of ssODN bearing the single-nucleotide variant of c.1066C>T, which changes the coded amino
acid from arginine to cysteine. A synonymous variant at c.1068T>C was also introduced to create a HhaI recognition site, GCGC, to aid in
mouse genotyping. (c) Chromatograms from Sanger sequencing are shown for homozygous wild-type (WT/WT), heterozygous (WT/MT), and
homozygous variant (MT/MT). Arrows indicate the location of missense variants. (d) Genotyping the wild-type (WT), heterozygous (HT), and
homozygous variant (MT) mice. The variant PCR product will be cut into two bands (260 and 210 bp) by HhaI if there is a variant allele
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histology was not significantly different from wild-type
mice.
A recent study identified a consanguineous family of
Palestinian origin, in which four females exhibited HH
(Weinberg-Shukron et al., 2015). These investigators used
homozygosity mapping and WES to identify a recessive
missense variant in nucleoporin 107 (NUP107, c.1339G>A,
p.D447N). This variant segregated with the phenotype and
was not present in available databases or in 150 healthy
ethnically matched controls. The investigators then used
transgenic rescue of Drosophila females bearing the human
homolog, Nup107 D364N variant, to show subfertility phe-
notype, with a marked reduction in progeny, morphologi-
cally aberrant eggshells, and disintegrating egg chambers,
indicating defective oogenesis. Their results indicated a role
for NUP107 in ovarian development and suggest that
nucleoporin defects may play a role in HH. It is interesting
to note that NUP107 positively charged R355 and K278
form salt bridges with negatively charged D447 (Weinberg-
Shukron et al., 2015). These salt bridges are crucial in
maintaining the stability of the whole NUP107 protein and
variant of a corresponding site of human NUP107 D447
variant in Drosophila reduces female fertility, presumably
due to disrupted salt bridges (Weinberg-Shukron et al.,
2015). In the variant of arginine to cysteine, positive
charge is lost; however, mouse NUP107 protein function
seems not to be affected.
Our WES generated several plausible variants of
unknown significance. Nup107 (c.1066C>T, p.R355C)
variant was investigated further by introducing it in the
mouse. Mice are good models for human reproductive tract
disease, and replicate the human phenotype of HH for
many genes studies such as Fshr and Sohlh1 (Dierich
et al., 1998; Aittomaki et al., 1995; Katari et al., 2015;
Bayram et al., 2015). Missense variants, which result in
single or few nucleotide changes that convert one amino
acid to another are much more common, but more difficult
to functionally assess. Recent studies using CRISPR/Cas9
suggest that introduction of human variants into mice
reveals functionally significant missense variants (Singh &
Schimenti, 2015). Unlike our affected daughters that were
infertile and had small ovaries, Nup107R356C female mice
were subfertile and ovaries were not hypoplastic. The dif-
ference between subfertility and total infertility could be
due to the basic difference between human and mouse
reproductive systems. Mice have large litter sizes as com-
pared to humans, and subfertility in mice may translate into
total infertility in humans. Alternatively, Nup107, despite
its conservation, may have different functions in the mouse
ovaries as compared to the human.
We conclude that Nup107 (c.1066C>T, p.R355C) vari-
ant falls in the category of variant of unknown clinical sig-
nificance, and further human studies are needed for
classification into benign or pathogenic category. This con-
clusion is based on the application of recent guidelines
issued by the American College of Medical Genetics and
Genomics and the Association for Molecular Pathology
(Richards et al., 2015). Over 500 genes and their variants
have been reported to disrupt hypothalamic–pituitary–go-
nadal axis and cause hypogonadism. Precise genetic diag-
nosis of such reproductive physiologic disturbances can
lead to appropriate hormonal replacement, correction of
underlying physiologic disturbance, and treatment of infer-
tility. ClinGen and ClinVar entries are underrepresented in
the description of pathogenic variants in infertility genes,
despite over 300 entries in OMIM. Commercial and aca-
demic laboratories offer multiple gene panels for infertility,
ovarian insufficiency, hypogonadism, and disorders of sex-
ual differentiation. Misinterpretation of pathogenicity of
such variants could lead to unnecessary medical interven-
tion, either hormonal or surgical. Curation and appropriate
interpretation of genetic variants is of great importance for
the future of precision reproductive medicine.
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